Medical technology company Smith & Nephew, through its subsidiaries, has entered into a definitive agreement to buy all the assets of Healthpoint Biotherapeutics for $782m in cash. Under the deal, Healthpoint in Texas which develops and ...
Tags: medical technology, Smith&Nephew, Healthpoint Biotherapeutic